Sequent Scientific Limited (BOM:512529)

Market Cap	42.07B
Revenue (ttm)	15.51B
Net Income (ttm)	218.78M
Shares Out	249.92M
EPS (ttm)	0.85
PE Ratio	198.06
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20,150
Average Volume	36,001
Open	170.30
Previous Close	175.85
Day's Range	170.30 - 174.30
52-Week Range	111.00 - 240.90
Beta	1.08
RSI	32.63
Earnings Date	May 21, 2025

About Sequent Scientific

Sequent Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides animal health active pharmaceutical ingredients (APIs) formulations in the areas of antihelmentic, anti-parasites, antiprotozoal, NSAID, anti-bacterial, phosphorus supplement, beta agonist, analgesic, antimetic, anti- allergic, and congestive heart failure. It also offers analytical services; and finished dosage formulations, and VET formulation. The company was formerly known as PI Drugs & Pharmaceuticals Ltd. an...

• Industry: Pharmaceutical Preparations
• Founded: 1985
• Employees: 1,244
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 512529